Associate Professor (Adj) Kelvin Teo
MBBS, PhD
MBBS (London, United Kingdom)
FAMS (Singapore)
PhD (Sydney, Australia)
Senior Consultant, Advanced Eye Clinic & Surgery
Adj Associate Professor, Duke NUS Ophthalmology & Visual Sciences Academic Clinical Programme
Retina and Cataract specialist, with expertise in macular degeneration, diabetic eye disease, and complex retinal conditions.
Clinician and researcher at Duke-NUS and the Singapore Eye Research Institute, focused on care for the aging eye.
Published researcher in retinal diseases regularly invited to speak at international and local ophthalmology conferences, delivering research-informed, patient centred care.
Years as Senior Consultant at Singapore National Eye Centre (SNEC)
0
+
Years dedicated to clinical practice and research in retinal diseases
0
+
Peer-reviewed publications in leading ophthalmology journals
0
Research funding secured, including prestigious NMRC awards
$
0
m+
Anti-Complement Therapy for Geographic Atrophy Administered by Dr Teo
On 31 October 2024, Dr Kelvin Teo administered anti-complement therapy for geographic atrophy (GA) at Mount Elizabeth Hospital under early-access approval. This is the first such treatment administered in Singapore.
Geographic atrophy is an advanced form of dry age-related macular degeneration (AMD) that can lead to central vision loss. While wet AMD can be managed with anti-VEGF injections, treatment options for GA have been limited until recently.
The therapy administered was Izervay (avacincaptad pegol), which has been evaluated in Phase 3 clinical trials (GATHER1 & GATHER2) for its ability to address GA lesion growth. This procedure was carried out on a named-patient basis under early-access approval.
AMD affects over 200 million people globally, with increasing prevalence in Asia’s aging populations. AMD includes two subtypes: wet and dry, with the dry form being more common. Anti-complement therapies such as Izervay work by targeting the complement pathway, part of the immune system involved in retinal cell damage in GA.
Dr Teo is a retina specialist with clinical focus on complex retinal conditions including angiogenic and atrophic macular degeneration. He is an Adjunct Associate Professor at Duke-NUS Medical School and has published over 100 peer-reviewed papers. He maintains a research focus on retinal therapies and imaging while in private practice.
Clinical Expertise
Age-related macular degeneration
Medical management including anti-VEGF injections, laser therapy and novel therapies for AMD including new treatment for dry early/late AMD
Diabetic retinopathy
Comprehensive treatment for diabetic eye disease including early screening and detection to management of complex diabetic retinopathy and macular oedema with intravitreal injections, laser photocoagulation and other therapies
Acute retina conditions
Emergency and elective surgical repair for acute retina conditions
Inherited retinal diseases
Diagnosis and management of retinitis pigmentosa and other inherited conditions, including genetic screening, counseling, and potential access to novel therapies if appropriate
Associate Professor Kelvin Teo is a senior consultant ophthalmologist at Advanced Eye Clinic and Surgery, with a special focus on complex retinal diseases. He is a cataract surgeon and retinal specialist with clinical expertise in age-related macular degeneration, diabetic eye disease, and retinal vascular disorders.
Dr Teo graduated from Barts and The London School of Medicine and Dentistry, and went on to earn a PhD in Medical Research from the University of Sydney. He completed his ophthalmology specialist training at the Singapore National Eye Centre (SNEC), where he practised for over a decade. His dual fellowships in Medical Retina—one from SNEC and the other from the Sydney Eye Hospital—further deepened his subspecialty expertise.
As an adjunct Associate Professor at the Ophthalmology & Visual Sciences Academic Clinical Programme (EYE ACP), Duke-NUS Medical School, and a lead researcher at the Singapore Eye Research Institute (SERI), A/Prof Teo actively contributes to research on the aging eye, macular degeneration, and retinal imaging and treatment. He has authored over 150 peer-reviewed publications and secured major national research funding, including the NMRC Transition Award.
A/Prof. Teo is invited to speak at international conferences, academic forums, and industry events. He works closely with global research networks and pharmaceutical partners on retinal therapeutics. Through his involvement in clinical trials and translational research, he offers patients access to treatments and technologies, delivering individualised care for complex retinal conditions.
A/Prof Kelvin Teo’s Clinical Services:
- Intravitreal injections performed with techniques to minimise discomfort
- Cataract surgery for eyes with complex retinal conditions, combining safety with optimal visual outcomes
- Diagnostics and imaging for accurate assessment and treatment planning
- Personalised care plans tailored to each patient’s specific condition and needs
- Participation in treatments that are undergoing clinical trials and research collaborations
*Full citation and research papers available here